FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994924922> ?p ?o ?g. }

• W1994924922 abstract "Article Abstract ABSTRACT Objective: To assess the rate and typology of sexual dysfunction in male subjects receiving trifluoperazine, risperidone, or olanzapine using the Arizona Sexual Experience Scale (ASEX), the Psychotropic Related Sexual Dysfunction Questionnaire (PRSexDQ), and the sexual function section of the modified Udvalg for Kliniske Undersøgelser Side Effect Rating Scale (UKU). Method: The sample included 100 men with psychotic disorders (F2 category of the ICD-10) and receiving trifluoperazine (n = 20), risperidone (n = 30), or olanzapine (n = 50) for at least 3 months†duration. Subjects with a history of sexual dysfunction prior to antipsychotic intake or chronic medical illness were excluded. A cross-sectional design was employed, and data were collected over a 1½-year period from March 2009 to August 2010. Results: The rate of sexual dysfunction varied from scale to scale among the 100 subjects. The rate of sexual dysfunction was 25% on the ASEX, 37% on the PRSexDQ, and 40% on the UKU. Sexual dysfunction in the trifluoperazine, risperidone, and olanzapine groups was 20%, 43%, and 16%, respectively, on the ASEX; 35%, 50%, and 30%, respectively, on the PRSexDQ; and 40%, 50%, and 34%, respectively, on the UKU. The most common sexual dysfunction as assessed on all scales was decreased libido, except for the risperidone group on the ASEX. Conclusions: Sexual dysfunction is quite prevalent in subjects receiving antipsychotic medications. In our study, rate of sexual dysfunction was highest for risperidone, followed by trifluoperazine and olanzapine. However, the rate of sexual dysfunction varied from scale to scale. Hence, there is a need for a comprehensive instrument to assess sexual dysfunction in patients receiving antipsychotics. Prim Care Companion CNS Disord 2012;14(2):doi:10.4088/PCC.11m01199 © Copyright 2012 Physicians Postgraduate Press, Inc. Submitted: April 14, 2011; accepted June 15, 2011. Published online: April 26, 2012. Corresponding author: Sandeep Grover, MD, Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India (drsandeepg2002@yahoo.com)." @default.
• W1994924922 created "2016-06-24" @default.
• W1994924922 creator A5022898750 @default.
• W1994924922 creator A5037986670 @default.
• W1994924922 creator A5075391800 @default.
• W1994924922 date "2012-04-26" @default.
• W1994924922 modified "2023-10-02" @default.
• W1994924922 title "Sexual Dysfunction in Male Subjects Receiving Trifluoperazine, Risperidone, or Olanzapine" @default.
• W1994924922 cites W1579022733 @default.
• W1994924922 cites W1622970938 @default.
• W1994924922 cites W1712504441 @default.
• W1994924922 cites W1821416578 @default.
• W1994924922 cites W1965507729 @default.
• W1994924922 cites W1974944326 @default.
• W1994924922 cites W1975768376 @default.
• W1994924922 cites W1980366779 @default.
• W1994924922 cites W1987902149 @default.
• W1994924922 cites W1988082497 @default.
• W1994924922 cites W2008008152 @default.
• W1994924922 cites W2009394319 @default.
• W1994924922 cites W2014151794 @default.
• W1994924922 cites W2022320465 @default.
• W1994924922 cites W2023722252 @default.
• W1994924922 cites W2035819314 @default.
• W1994924922 cites W2037132263 @default.
• W1994924922 cites W2038782032 @default.
• W1994924922 cites W2039549833 @default.
• W1994924922 cites W2040008186 @default.
• W1994924922 cites W2047265111 @default.
• W1994924922 cites W2048570687 @default.
• W1994924922 cites W2049924226 @default.
• W1994924922 cites W2064011042 @default.
• W1994924922 cites W2074921851 @default.
• W1994924922 cites W2080468819 @default.
• W1994924922 cites W2085636772 @default.
• W1994924922 cites W2086239574 @default.
• W1994924922 cites W2086823117 @default.
• W1994924922 cites W2094354096 @default.
• W1994924922 cites W2098644261 @default.
• W1994924922 cites W2119226169 @default.
• W1994924922 cites W2125515120 @default.
• W1994924922 cites W2132204611 @default.
• W1994924922 cites W2164182651 @default.
• W1994924922 cites W2166392515 @default.
• W1994924922 cites W2245266565 @default.
• W1994924922 cites W2432947781 @default.
• W1994924922 doi "https://doi.org/10.4088/pcc.11m01199" @default.
• W1994924922 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3425461" @default.
• W1994924922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22943029" @default.
• W1994924922 hasPublicationYear "2012" @default.
• W1994924922 type Work @default.
• W1994924922 sameAs 1994924922 @default.
• W1994924922 citedByCount "9" @default.
• W1994924922 countsByYear W19949249222014 @default.
• W1994924922 countsByYear W19949249222015 @default.
• W1994924922 countsByYear W19949249222017 @default.
• W1994924922 countsByYear W19949249222019 @default.
• W1994924922 countsByYear W19949249222021 @default.
• W1994924922 countsByYear W19949249222023 @default.
• W1994924922 crossrefType "journal-article" @default.
• W1994924922 hasAuthorship W1994924922A5022898750 @default.
• W1994924922 hasAuthorship W1994924922A5037986670 @default.
• W1994924922 hasAuthorship W1994924922A5075391800 @default.
• W1994924922 hasBestOaLocation W19949249222 @default.
• W1994924922 hasConcept C118552586 @default.
• W1994924922 hasConcept C126322002 @default.
• W1994924922 hasConcept C15744967 @default.
• W1994924922 hasConcept C2775871022 @default.
• W1994924922 hasConcept C2775891158 @default.
• W1994924922 hasConcept C2776412080 @default.
• W1994924922 hasConcept C2776619155 @default.
• W1994924922 hasConcept C2778093883 @default.
• W1994924922 hasConcept C2779366285 @default.
• W1994924922 hasConcept C2780057945 @default.
• W1994924922 hasConcept C29688787 @default.
• W1994924922 hasConcept C519063684 @default.
• W1994924922 hasConcept C71924100 @default.
• W1994924922 hasConceptScore W1994924922C118552586 @default.
• W1994924922 hasConceptScore W1994924922C126322002 @default.
• W1994924922 hasConceptScore W1994924922C15744967 @default.
• W1994924922 hasConceptScore W1994924922C2775871022 @default.
• W1994924922 hasConceptScore W1994924922C2775891158 @default.
• W1994924922 hasConceptScore W1994924922C2776412080 @default.
• W1994924922 hasConceptScore W1994924922C2776619155 @default.
• W1994924922 hasConceptScore W1994924922C2778093883 @default.
• W1994924922 hasConceptScore W1994924922C2779366285 @default.
• W1994924922 hasConceptScore W1994924922C2780057945 @default.
• W1994924922 hasConceptScore W1994924922C29688787 @default.
• W1994924922 hasConceptScore W1994924922C519063684 @default.
• W1994924922 hasConceptScore W1994924922C71924100 @default.
• W1994924922 hasLocation W19949249221 @default.
• W1994924922 hasLocation W19949249222 @default.
• W1994924922 hasLocation W19949249223 @default.
• W1994924922 hasLocation W19949249224 @default.
• W1994924922 hasOpenAccess W1994924922 @default.
• W1994924922 hasPrimaryLocation W19949249221 @default.
• W1994924922 hasRelatedWork W1975768376 @default.
• W1994924922 hasRelatedWork W1994924922 @default.
• W1994924922 hasRelatedWork W2038782032 @default.
• W1994924922 hasRelatedWork W2111083453 @default.

• next